ASCO-GU 2024
Jan 25 - 27, 2024 | San Francisco, CA
The agents listed below are currently under investigation. Their safety and efficacy have not been established.
Poster
Real-World Outcomes of Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Tumors Harboring Androgen Receptor (AR) Ligand-Binding Domain (LBD) MutationsTF Stewart et al